Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)

PURPOSE: To explore the combination of clofarabine, cytarabine, and idarubicin (CIA) in patients with newly diagnosed acute myeloid leukemia (AML) </= 60 years. PATIENTS AND METHODS: Patients ≥18-60 years with AML and adequate organ functions were candidates. Induction therapy consisted of clofar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nazha, Aziz, Ravandi, Farhad, Kantarjian, Hagop, Huang, Xuelin, Choi, Sangbum, Garcia-Manero, Guillermo, Jabbour, Elias, Borthakur, Gautam, Kadia, Tapan, Konopleva, Marina, Cortes, Jorge, Ferrajoli, Alessandra, Kornblau, Steve, Andreeff, Michael, Du, Min, Brandt, Mark, Faderl, Stefan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110914/
https://ncbi.nlm.nih.gov/pubmed/23877926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23544
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares